| Tag | Content |
|---|
EnhancerAtlas ID | HS060-19652 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr2:88917840-88919870 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EN2 | MA0642.1 | chr2:88919357-88919367 | GCTAATTGGG | - | 6.02 | | ZNF263 | MA0528.1 | chr2:88919774-88919795 | ACCCTCTCTCCCCTCTCCTTC | - | 6.17 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_10491 | chr2:88917445-88918650 | CD19_Primary | | SE_11125 | chr2:88893822-88930665 | CD20 | | SE_43929 | chr2:88917012-88918504 | MM1S | | SE_58772 | chr2:88890746-88928380 | Ly1 | | SE_60725 | chr2:88890414-88928580 | DHL6 | | SE_62662 | chr2:88894659-88928826 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH02I088617 | chr2 | 88917013 | 88918650 | | GH02I088619 | chr2 | 88919203 | 88920498 |
|
Enhancer Sequence | CTTATTCAAG AATTGAAGGA ACTGCAGAGA CAGCTTTTCC AGTGGAAAGA ACCAAAGCCT 60
AAGTCAGACC TGGGTGTACA TCCCCAAGGC TCTCCTCTCA TTCTCCTCAT GGCTTCATTC 120
GAGTTATTTT TTCATAGGCA AAATATGGTT ATTTCACCTA TCTCAGTGTA ACCCAAGTGT 180
ACCTGATCAT AAAAATAATC TGGAGTGCTT GTTAAAAACC ATTAAAGGTT CCCACGTCTC 240
ATCCTAAGAG GGAGACTGGG AGAATGTAGC CTAACAAGCA CCCCAGGTGA GTCTCATAAG 300
ACCAGTTGTG CAAACACTGT TTTACCTTAG TCATTTCCAT AGAGAAAAAT TAAATTTATG 360
ATGTGGATGA AGAAGGCATA TTGAACATCT CTGTCAGTAA ATACTTTGGA GACTTCTGTC 420
TCTCACTTAC ATTTTGCTGT AGCTTACAAA AGCATTTATT TGGATGATTC CTCAGCAAGC 480
CCTGAACTCT CACCCATGAT CCAATCCTTG GAAGCCACTC TCAAGAAAGA TTTTCAATGG 540
TTTCCTAACT GCCAGATTCA CTCCCCTCAT CAGGCCTGTC TTCACAAAAG CCACCGTTGT 600
GGCCAGCTCC TCATTCTGGA CATTTTTCTT TCCTGGTTTC TACAGGACCA GTCCCTCCTG 660
GGTCCTCATC TATCATTCTT TTTTTTTTTT TTTGGGGGGA CGGAGTCTTG CTCTGTCGCC 720
CAATGGTACG ATCTCTGCTC AATGGCAACC TCCGCCTCCC AGGTTCAAGC GATTCTCCTG 780
CCTCAGCCTC CCAAGTAGCT GGGATTACAG GTGCCCACCA CCATGCCCAG CTAATTTTTG 840
TATTTTTTAG TAGAGGTGGG GGTTCACCAT GTTGGCCAGG CTGGTCTCGA GCTCCTGACC 900
TCAGGTGATC TGCCCGCTTC AGCCTCCTAA AGTGCTGGGA TTATAGGCGT GAGCCACCGT 960
GCCCGGCCTC ACCTATCATC CTTATAGTTT TCTATCTATA GAGCAGGCAT TTTCCTGTTT 1020
GTACTACATG TTCTACCTAG ATGGTCAATG TCTACAGCTT CACCTCCATC TATAGTATGA 1080
CAGCCCCCAA ACCTGTACAG GATTTATAGT TCACCATCTC TCCCCTATCC TAGTTCTGCA 1140
TCTTCAGCAG GATCTACTTG TTATCACCAT AACAGGCTCA GGAAACTTCT TTCCCACAAT 1200
CTATTCCTGC CACTTAAAAG GGTAGCCATC CATCCTATTA CCTAACATTT AAATCAGACA 1260
TCAACTCTTT GTGCTCCCTC ATCCTCTACA TTTAAACAAC AGCCATGTAC TCTTAATTCT 1320
ATTTCTGAAG CTTCTCTTAA ATCTTTTCTG GCTGGGCACG GTGACTCACC CCTGTAATCC 1380
CAGCACTTTG GGAGGCCAAG GCGGATGGAT CACCTGAGAT CAGGAGTTCA AGACCAACCC 1440
GGCCAACATG GTGAAACCCT ATCTCTACTA AAAATACAAA AGTAAGCCGG GTGTGATGGC 1500
ATGCACCTGT AATCCCAGCT AATTGGGAGA GGCTGAGACA GGAGAATCAC TTGAACCTGG 1560
GAGGCGGAGG TTGCAGTAAG CTAAGATTGC ACCACTGCAC TCCAGCCTGC ACGACAGAGC 1620
GAGACTCCGT CTCAAAAAAA AAAAAAAAAA AAATCTTTGC CTTCTTCATT ACCACAGCTC 1680
TTGCTCTAGA AGATTCTCAT TTCTCATCAG AACACCTTAA AATGCTTTCT AACACATTTT 1740
CCTGCCTCAG GTTTCTTTCC CCTCTCTTCT TCCCACAGTT TTGTTTCTGT AATAGAGATC 1800
TGATAAACTT CCAAGGTTCC CTGTGCCCAC TGAAAAAGAA AGGTCACACT GCTTGGTGTG 1860
GCACATAAAG CCTTTCACAA TTTGGTTTCG GTGTACTTTC CTAATCTCAT TTTTCTGCCT 1920
CTTGTACCAG CCCAACCCTC TCTCCCCTCT CCTTCCCAGC TCCACACTCC CCCCTTTCCA 1980
TGGGGTGAAC TTTTCAAAAG TTCTCTTGTC TATATTTTCC TCCATGTCTT 2030
|
